Eastman Chemical Company (NYSE: EMN) reported lower sales and adjusted profit for the second quarter of 2023. The management provided guidance for the full fiscal year.
- Total sales revenue decreased to $2.32 billion in the second quarter from $2.78 billion in the corresponding period of 2022
- The chemical company reported adjusted earnings of $1.99 per share for the three-month period, lower than the $2.83 per share profit it reported a year earlier
- Unadjusted profit, on a per-share basis, came in at $2.27, compared to $2.03 in the prior-year quarter
- Net cash provided by operating activities was $410 million in the second quarter, vs. $245 million last year
- Q2 adjusted EBITDA decreased to $336 million from $469 million in the year-ago period
- The company said it expects the auto, aviation, and other markets to modestly improve in the second half of the year
- Eastman is looking for earnings in the range of $6.50 per share to $7.00 per share for fiscal 2023
- It continues to expect to generate $1.4 billion of operating cash flow this year
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
DIS Earnings: All you need to know about Walt Disney’s Q4 2025 earnings results
The Walt Disney Company (NYSE: DIS) reported its fourth quarter 2025 earnings results today. Revenues of $22.5 billion were comparable to the year-ago quarter. Net income attributable to The Walt
Cisco (CSCO) reports higher Q1 revenue and earnings; results beat estimates
Network gear maker Cisco Systems Inc. (NASDAQ: CSCO) on Wednesday announced financial results for the first quarter of fiscal 2026, reporting higher revenue and profit. Earnings, on an adjusted basis,
Advantage of CERo’s CER receptor lies in native human protein-based antigen binding: CEO
CERo Therapeutics Holdings, Inc. is a biotechnology company pioneering engineered T cell immunotherapies to combat cancer, with a focus on hematologic malignancies and solid tumors. In an email conversation with
